Efficacy and Long-Term Outcome of Treatment for Pure Red Cell Aplasia after Allogeneic Stem Cell Transplantation from Major ABO-Incompatible Donors-Reference-Cited by-同舟云学术

Efficacy and Long-Term Outcome of Treatment for Pure Red Cell Aplasia after Allogeneic Stem Cell Transplantation from Major ABO-Incompatible Donors

Published:2013-07 Issue:7 Volume:19 Page:1026-1032
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Hirokawa Makoto,Fukuda Takahiro,Ohashi Kazuteru,Hidaka Michihiro,Ichinohe Tatsuo,Iwato Koji,Kanamori Heiwa,Murata Makoto,Sakura Toru,Imamura Masahiro,Adachi Soichi,Suzuki Ritsuro,Morishima Yasuo,Sakamaki Hisashi

Funder

Ministry of Education, Science, Sports, and Culture of Japan

“Global Center of Excellence Program (COE)” of the Ministry of Education, Science, Technology, Sports, and Culture of Japan

Idiopathic Disorders of Hematopoietic Organs Research Committee of the Ministry of Health, Labour, and Welfare of Japan

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference41 articles.

1. Diagnosis and management of acquired pure red cell aplasia;Sawada;Hematol Oncol Clin North Am,2009

2. Acquired pure red cell aplasia: Updated review of treatment;Sawada;Br J Haematol,2008

3. Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group;Sawada;Haematologica,2007

4. Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: A nationwide cohort study in Japan by the PRCA collaborative study group;Hirokawa;Haematologica,2008

5. Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: A nationwide cohort study in Japan for the PRCA Collaborative Study Group;Fujishima;Haematologica,2008

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seven-years post allogeneic hematopoietic stem cell transplantation pure red cell aplastic anemia cured with daratumumab: A case report and review of literature;World Journal of Clinical Cases;2024-08-26

2. Pure Red Cell Aplasia - Post Major ABO Incompatible Allogenic Stem Cell Transplantation Role of Ibrutinib;Journal of Stem Cell Therapy and Transplantation;2024-07-24

3. Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review;Frontiers in Oncology;2024-07-02

4. Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC;Bone Marrow Transplantation;2024-03-09

5. Successful treatment of a pure red cell aplasia patient following ABO-mismatched hematopoietic stem cell transplantation from a sibling donor with multiple sclerosis;Transplant Immunology;2023-08